Review



rabbit anti human hpv16 e6 antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bioss rabbit anti human hpv16 e6 antibody
    (A) Image shows 4% agarose electrophoresis of GAPDH, miR-187, HPV18 E6/E7, <t>HPV16</t> E6/E7, and U6 PCR products. (B) Melting curves of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. M: 20-bp DNA marker.
    Rabbit Anti Human Hpv16 E6 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human hpv16 e6 antibody/product/Bioss
    Average 94 stars, based on 4 article reviews
    rabbit anti human hpv16 e6 antibody - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6"

    Article Title: MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

    Journal: Oncotarget

    doi: 10.18632/oncotarget.17516

    (A) Image shows 4% agarose electrophoresis of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. (B) Melting curves of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. M: 20-bp DNA marker.
    Figure Legend Snippet: (A) Image shows 4% agarose electrophoresis of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. (B) Melting curves of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. M: 20-bp DNA marker.

    Techniques Used: Electrophoresis, Marker

    (A) Detection of miR-187 expression levels after mimics transfection. (B) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was decreased (*P < 0.05). (C) Corresponding increased expression of p53 protein compared to NC and blank groups (*P < 0.05). (D) Detection of miR-187 expression levels after inhibitor transfection. (E) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was increased (*P < 0.05). (F) Decreased p53 protein expression (*P < 0.05).
    Figure Legend Snippet: (A) Detection of miR-187 expression levels after mimics transfection. (B) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was decreased (*P < 0.05). (C) Corresponding increased expression of p53 protein compared to NC and blank groups (*P < 0.05). (D) Detection of miR-187 expression levels after inhibitor transfection. (E) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was increased (*P < 0.05). (F) Decreased p53 protein expression (*P < 0.05).

    Techniques Used: Expressing, Transfection

    (A) HPV16 E6 mRNA levels detected in the presence of miR-187 mimics or miR-187 inhibitor (**P < 0.01, ***P <0.001). (B) Western blot detection of HPV16 E6 protein levels in CaSki cells in the presence of miR-187 mimics (***P <0.001). (C) Bioinformatics prediction of the miR-187 binding sites of the HPV16 E6 3′ UTR. The mutated HPV16 E6 3′ UTR is also shown. (D) Luciferase activity of CHO cells co-transfected with miR-187 expression vector or empty vector and HPV16 E6 3′ UTR reporter plasmid or its mutant form for 48 h. Data shown are the means ± SD of three replicates (**P < 0.01).
    Figure Legend Snippet: (A) HPV16 E6 mRNA levels detected in the presence of miR-187 mimics or miR-187 inhibitor (**P < 0.01, ***P <0.001). (B) Western blot detection of HPV16 E6 protein levels in CaSki cells in the presence of miR-187 mimics (***P <0.001). (C) Bioinformatics prediction of the miR-187 binding sites of the HPV16 E6 3′ UTR. The mutated HPV16 E6 3′ UTR is also shown. (D) Luciferase activity of CHO cells co-transfected with miR-187 expression vector or empty vector and HPV16 E6 3′ UTR reporter plasmid or its mutant form for 48 h. Data shown are the means ± SD of three replicates (**P < 0.01).

    Techniques Used: Western Blot, Binding Assay, Luciferase, Activity Assay, Transfection, Expressing, Plasmid Preparation, Mutagenesis

    Primer sequences
    Figure Legend Snippet: Primer sequences

    Techniques Used: Sequencing



    Similar Products

    rabbit anti human hpv16 e6 antibody  (Bioss)
    94
    Bioss rabbit anti human hpv16 e6 antibody
    (A) Image shows 4% agarose electrophoresis of GAPDH, miR-187, HPV18 E6/E7, <t>HPV16</t> E6/E7, and U6 PCR products. (B) Melting curves of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. M: 20-bp DNA marker.
    Rabbit Anti Human Hpv16 E6 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human hpv16 e6 antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit anti human hpv16 e6 antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Image shows 4% agarose electrophoresis of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. (B) Melting curves of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. M: 20-bp DNA marker.

    Journal: Oncotarget

    Article Title: MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

    doi: 10.18632/oncotarget.17516

    Figure Lengend Snippet: (A) Image shows 4% agarose electrophoresis of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. (B) Melting curves of GAPDH, miR-187, HPV18 E6/E7, HPV16 E6/E7, and U6 PCR products. M: 20-bp DNA marker.

    Article Snippet: Rabbit anti-human HPV16 E6 antibody (BS1719-R, 1:400) was purchased from BIOSS.

    Techniques: Electrophoresis, Marker

    (A) Detection of miR-187 expression levels after mimics transfection. (B) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was decreased (*P < 0.05). (C) Corresponding increased expression of p53 protein compared to NC and blank groups (*P < 0.05). (D) Detection of miR-187 expression levels after inhibitor transfection. (E) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was increased (*P < 0.05). (F) Decreased p53 protein expression (*P < 0.05).

    Journal: Oncotarget

    Article Title: MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

    doi: 10.18632/oncotarget.17516

    Figure Lengend Snippet: (A) Detection of miR-187 expression levels after mimics transfection. (B) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was decreased (*P < 0.05). (C) Corresponding increased expression of p53 protein compared to NC and blank groups (*P < 0.05). (D) Detection of miR-187 expression levels after inhibitor transfection. (E) Relative expression of HPV18 E6/E7 and HPV16 E6/E7 mRNA; HPV16 E6 mRNA was increased (*P < 0.05). (F) Decreased p53 protein expression (*P < 0.05).

    Article Snippet: Rabbit anti-human HPV16 E6 antibody (BS1719-R, 1:400) was purchased from BIOSS.

    Techniques: Expressing, Transfection

    (A) HPV16 E6 mRNA levels detected in the presence of miR-187 mimics or miR-187 inhibitor (**P < 0.01, ***P <0.001). (B) Western blot detection of HPV16 E6 protein levels in CaSki cells in the presence of miR-187 mimics (***P <0.001). (C) Bioinformatics prediction of the miR-187 binding sites of the HPV16 E6 3′ UTR. The mutated HPV16 E6 3′ UTR is also shown. (D) Luciferase activity of CHO cells co-transfected with miR-187 expression vector or empty vector and HPV16 E6 3′ UTR reporter plasmid or its mutant form for 48 h. Data shown are the means ± SD of three replicates (**P < 0.01).

    Journal: Oncotarget

    Article Title: MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

    doi: 10.18632/oncotarget.17516

    Figure Lengend Snippet: (A) HPV16 E6 mRNA levels detected in the presence of miR-187 mimics or miR-187 inhibitor (**P < 0.01, ***P <0.001). (B) Western blot detection of HPV16 E6 protein levels in CaSki cells in the presence of miR-187 mimics (***P <0.001). (C) Bioinformatics prediction of the miR-187 binding sites of the HPV16 E6 3′ UTR. The mutated HPV16 E6 3′ UTR is also shown. (D) Luciferase activity of CHO cells co-transfected with miR-187 expression vector or empty vector and HPV16 E6 3′ UTR reporter plasmid or its mutant form for 48 h. Data shown are the means ± SD of three replicates (**P < 0.01).

    Article Snippet: Rabbit anti-human HPV16 E6 antibody (BS1719-R, 1:400) was purchased from BIOSS.

    Techniques: Western Blot, Binding Assay, Luciferase, Activity Assay, Transfection, Expressing, Plasmid Preparation, Mutagenesis

    Primer sequences

    Journal: Oncotarget

    Article Title: MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

    doi: 10.18632/oncotarget.17516

    Figure Lengend Snippet: Primer sequences

    Article Snippet: Rabbit anti-human HPV16 E6 antibody (BS1719-R, 1:400) was purchased from BIOSS.

    Techniques: Sequencing